Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. RTB
5. ONON
6. AAPL
7. NUE
8. AZN
9. SPCX
10. TRMD

Go back to Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 3.91 -0.23 (5.56%)
Previous Close $4.14    52 Week High $45.34 
Open $4.15    52 Week Low $15.92 
Day High $4.17    P/E 1.68 
Day Low $3.89    EPS $2.33 
Volume 1,707,387       

(NASDAQ: SOPH) Delayed: 8.24 -0.29 (3.4%)
Previous Close $8.53    52 Week High $ 
Open $8.55    52 Week Low $ 
Day High $8.70    P/E N/A 
Day Low $8.15    EPS $ 
Volume 647,391